Photoaging Clinical Trial
Official title:
Efficacy and Safety of Profile HaloTM Dual-wavelength Fusion Fractional Laser on the Treatment of Facial and Neck Photoaging: a Self-controlled Trial.
Verified date | May 2019 |
Source | Xijing Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
1. Fractional laser has become an important laser modality in management of a number of
skin conditions and photoaging. Fractional photothermolysis is the fractional emission
of light into microscopic treatment zones, creating small columns of injury to the skin
in a pixilated fashion. Epidermal and dermal disruptions occur in these focal zones of
thermal injury, stimulating dermal collagen production and elastic tissue formation.
Fractional laser has been used successfully to treat photodamage and overall dyschromia
in the Caucasian population. However, there is not much improvement in Asian population.
2. Photoaging refers to the skin caused by intense and chronic exposure to sunlight. The
visible effects of photoaging are fine wrinkles, mottling, pigmentation and roughness of
the skin. These changes are usually associated with chronologic aging. However,
photoaging is not a good indicator of chronologic age. It just makes a person look older
than his or her chronologic age. Skin ageing may be divided into two processes:
intrinsic ageing and extrinsic ageing (or photoageing). Both are accompanied by changes
in the morphological and biomechanical properties of skin.
3. Profile HaloTM dual-wavelength fusion fractional laser is the first hand tool in the
world that integrates ablative and non-ablative fractional lasers. It includes a
non-ablative fractional laser with a wavelength of 1470nm and an ablative fractional
laser with a wavelength of 2940nm. A day after treatment, new epithelial tissue began to
appear, and the necrotic epidermis formed microepidermal necrotic debris (MENDs). MENDs
were surrounded by keratin 2-7 days after treatment, and collagen sequence in MTZs was
changed 7 days later. The 2940 ablative fractional laser can be added with 20-100 micron
lattice stripping, ensuring safety while enabling MENDs to be peeled off 2 days earlier
and reducing the risk of side effects. This makes the laser safe and effective compared
with the single fractional laser and reduces the downtime.
Status | Completed |
Enrollment | 15 |
Est. completion date | October 1, 2017 |
Est. primary completion date | October 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Subjects must be clinically diagnosed by the investigator to facial photoaging dover 2-4 and cervical stripe Fitzpatrick 1-2.5 - no other treatment was performed for the skin lesions for half a year before the treatment - patients with a "no" in any of the above criteria are not eligible for inclusion Exclusion Criteria: - subjects with a recent history of exposure to sunlight; - subjects allergic to topical anesthesia; - subjects with scar constitution; - subjects with skin malignant tumors or precancerous lesions; .subjects with diabetes, heart disease, epilepsy, connective tissue disease, etc. - subjects who Pregnant or breast feeding; - subjects with recent skin infections (such as viruses, bacteria, etc.); - ther methods are being used to treat subjects with similar diseases; - subject who have taken isotretinoin A in the past year; .subject with facial dermatitis. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
xjpfW | Air Force General Hospital of the PLA, Chinese Academy of Medical Sciences, First Hospital of China Medical University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | VISIA skin test | With fast capture times and lighting modes designed to enhance the visualization of skin features, VISIA®-CR (Canfield Scientific, Inc. USA) is the standard in repeatable clinical imaging. Visia CR imaging system can be used to assess the skin wrinkles, texture, pores and elasticity | change from week0 to week48 | |
Secondary | Neck (Fitzpatrick wrinkle grading) | Level 0: no wrinkles, no visible wrinkles and continuous skin lines; Level 0.5: very shallow wrinkles visible to the naked eye Level 1: fine wrinkles, slight depressions visible to naked eye Level 1.5: visible wrinkles and clear depressions with a depth of <0.01mm; Level 2: medium wrinkles. It can be clearly seen that the depth of wrinkles is 1-2mm. Level 2.5: obvious visible wrinkles with a depth of 2-3mm; Level 3: deep wrinkles, visible deep marks, depth greater than > 3mm |
week0,week48 | |
Secondary | Glogau Classification of Photoaging | I: Mild 28-35 years old No wrinkles Early Photoaging: mild pigment changes, no keratosis, minimal wrinkles, minimal or no makeup; II: Moderate 35-50 years old Wrinkles in motion Early to Moderate Photoaging: Early brown spots visible, keratosis palpable but not visible, parallel smile lines begin to appear, wears some foundation; III: Advanced 50-65 years old Wrinkles at rest Advanced Photoaging: Obvious discolorations, visible capillaries (telangiectasias), visible keratosis, wears heavier foundation always; IV: Severe 60-75 years old Only wrinkles Severe Photoaging: Yellow-gray skin color, prior skin malignancies, wrinkles throughout—no normal skin, cannot wear makeup because it cakes and cracks | change from week0 to week48 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05271136 -
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
|
N/A | |
Completed |
NCT05514782 -
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
|
N/A | |
Completed |
NCT04911374 -
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
|
N/A | |
Completed |
NCT04586816 -
Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging
|
N/A | |
Not yet recruiting |
NCT05004909 -
Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream
|
N/A | |
Completed |
NCT05039723 -
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
|
Phase 4 | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05027282 -
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
|
N/A | |
Not yet recruiting |
NCT06096649 -
The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin
|
N/A | |
Completed |
NCT03661697 -
Combination Versus Laser Treatment Only
|
N/A | |
Completed |
NCT06148558 -
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
|
N/A | |
Enrolling by invitation |
NCT06188338 -
A 56-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Recruiting |
NCT06195605 -
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
|
N/A | |
Not yet recruiting |
NCT04869852 -
Effects of Mango Intake on Skin Health and Gut Microbiome Changes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT02126644 -
The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging
|
Phase 2 | |
Active, not recruiting |
NCT01372566 -
Effect of Platelet Rich Plasma on Photoaged Skin
|
Phase 1/Phase 2 | |
Unknown status |
NCT00842907 -
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
|
Phase 2 | |
Completed |
NCT03112863 -
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
|
Early Phase 1 | |
Recruiting |
NCT05386368 -
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
|
Phase 4 | |
Recruiting |
NCT05471947 -
TCA 15% Chemical Peel for Improvement in Hand Lentigines
|
Phase 4 |